chrisvoncsefalvay/vaers-outcomes huggingface dataset:
How could I possibly know which arm took which shot, the dose number of the vaccines and/or the manufacturers of the vacs?  Adverse Events: Within two hours of receiving the final vaccination on Oct. 9th, 2019, my face became red and somewhat rough to the touch. A particularly affected area was the skin around (both under and above) my eyes and between my eyebrows. This redness was noticeable enough for a friend I was visiting with that day who had no idea I received the vaccinations asked if I had been in a tanning bed. As the days progressed, the skin surrounding my eyes began flaking off from extreme dry skin. The redness and rough, dry skin continued down my entire face, beneath my chin and on the front of my neck. About a week later this red/dry skin condition was mostly gone. This said, since the vaccinations I have been experiencing unexplained patches itching on different places on my body. This itching shows up as small hive-like bumps surrounded by redness. As this skin condition comes and goes without warning, it is beyond difficult to schedule any examination to take place while symptomatic. Last night, Nov. 18, 2019 was my most recent experience with this itching.
This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (I was so shaky last night), CHEST DISCOMFORT (Weird chest sensation), PRURITUS (Itching), RASH (Rash in the mild of the night; all across the trunk of my body and the right /  rash come on my trunk, both breasts, under both arm pits, down the arms close to the elbow and then reappeared on the wrest and palm area on the right wrest) and NAUSEA (I am currently feeling a little nausea) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C48A21A and 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced NERVOUSNESS (I was so shaky last night), PRURITUS (Itching), RASH (Rash in the mild of the night; all across the trunk of my body and the right /  rash come on my trunk, both breasts, under both arm pits, down the arms close to the elbow and then reappeared on the wrest and palm area on the right wrest) and NAUSEA (I am currently feeling a little nausea). On an unknown date, the patient experienced CHEST DISCOMFORT (Weird chest sensation). The patient was treated with CALAMINE ongoing since an unknown date for Adverse event NOS, at an unspecified dose and frequency. On 29-Mar-2021, NERVOUSNESS (I was so shaky last night) had resolved. At the time of the report, CHEST DISCOMFORT (Weird chest sensation), PRURITUS (Itching) and NAUSEA (I am currently feeling a little nausea) outcome was unknown and RASH (Rash in the mild of the night; all across the trunk of my body and the right /  rash come on my trunk, both breasts, under both arm pits, down the arms close to the elbow and then reappeared on the wrest and palm area on the right wrest) had resolved. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient reported that rash had gone away completely and it was more like hives and it would come and go, sometimes visible for an hour then it would disappear. This lasted for 2 days and it resolved on its own. Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: follow up received contains additional event.
Pt tested positive for COVID on 02/29/2021. Passed away on 02/25/2021. COVID listed on death certificate.
Two days after receiving my first dose, I got a severe Migraine. It was one like I haven't had in at least ten years. I lost the ability to speak or say words. I took two tablets of Fiorinal and had to take another dose six hours later. I had tingling up and down my right arm and right leg. I called my Neurologist and she told me to go to the local hospital ER. While there, they performed a CT Scan and an MRI. Both tests came back normal. They didn't recommend any change in my medication. The very next day after my visit to the ER, my symptoms stopped.
Itchiness at the site of the injection on Sunday evening , the 7th day following  the vaccine injection. Monday morning (8th day), left arm was swollen  and hard around injection site. Tuesday is today - Upper Arm is still swollen and  itchy .
Information has been received from a teenage female athlete (runner) via a news report who in May 2008, was vaccinated with GARDASIL. In May 2008, within days of getting the vaccine, the patient became mysteriously ill and was hospitalized. The patient said she couldn't breathe and was really fatigued. Her chest was beginning to hurt like she was having an allergy or asthma attack. In July 2008, doctors diagnosed the patient with mononucelosis. As of 19-FEB-2009, the patient had not recovered and was still too weak to run. The patient's family thinks GARDASIL was responsible, but the patient's physician's did not know if her condition was related to the vaccine or if it was a coincidence. Additional information is not expected.
This spontaneous retrospective pregnancy report as received from a consumer (patient's husband) refers to a 30 year old female patient with no medical history or concurrent conditions reported. On 14-MAR-2014 the patient was given a urine pregnancy test which came out negative for pregnancy. The patient's husband reported that his wife was send to health department on 14-MAR-2014 to be given M-M-R II vaccine. Before the vaccine was given, the female was given a urine pregnancy test. The husband protested, stating that urine pregnancy tests are not 100% accurate. Both the husband and the patient were reassured that the test was accurate. On 14-MAR-2014 the patient was vaccinated with unspecified dose of M-M-R II (dose number, frequency and lot number not reported). Concomitant medications were not reported. The date of conception was approximately on 14-FEB-2014. On 16-MAR-2014 the patient started throwing up and feeling dizzy, was taken to her primary care physician's (PCP) office and a serum pregnancy test was done which was positive for pregnancy. It was reported that it was determined that the patient was a month and a half pregnant (approximately 6 weeks) at the time of vaccination on 14-MAR-2014. The patient became pregnant with Last Menstrual Period (LMP) of 31-JAN-2014 and Estimated Delivery Date (EDD) of 07-NOV-2014. On 26-APR-2014 the patient was at hospital where she was undergoing sonogram which showed that the fetus had not grown anymore and was dead. It was not known if any additional laboratory work was done confirming this. The reporter stated that the nurse gave them info to return to emergency room if the patient starts experiencing any bleeding or fever. The reporter stated that his wife was at home and is feeling tired and experienced pains in her stomach. The reporter stated as of 27-APR-2014, his wife has not started passing the products of conception. The outcomes of feeling tired, started throwing up, feeling dizzy and pains in her stomach were unknown. The relatedness between the events and M-M-R II was not reported. The reporter considered fetus had not grown anymore and was dead to be medically significant. Additional information has been requested.
Moderna COVID-19 Vaccine EUA.  A flash of fuzziness in front of eyes and felt like brain that lasted about 30 seconds (while driving home afterwards), and a burning feeling with tingling and then some numbness in upper lip up to top of nose. The burning felt similar to a rugburn. This lasted two days and is feeling  90% better at this moment.
METAL STUCK AT INJECTION SITE; SORE ARM; This spontaneous report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. The patient's past medical history included: opioid dependency, and concurrent conditions included: cigarette smoker, and alcohol use, and other pre-existing medical conditions included: The patient had no known allergies. Patient reported drug abuse for heroin then fentanyl on and off for 9 years. Patient reported that no taking fentanyl from 1 month ago. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-AUG-2021 for prophylactic vaccination. Concomitant medications included clonidine for drug used for unknown indication, and quetiapine fumarate for sleep disorder therapy.  On 12-AUG-2021, the patient experienced sore arm. On 14-AUG-2021, the patient experienced metal stuck at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sore arm, and metal stuck at injection site. This report was non-serious. This case, from the same reporter is linked to 20210830342.
Mother reported child had swollen eyes, vomiting, hives and a reddish complexion on face. Went to ER and was given Benadryl and something else. Doctors attributed this to Prevnar. Child all ok on morning of 1/4/01. Child received 4 vaccines on 3/7/01 (no Prevnar) and all is ok. Went to ER around 18:30 PM on evening of 1/3/01.
Patient had very little arm pain or muscle soreness on the day of the vaccination.  On 9/17/2020, 1 week after vaccination, patient developed left arm pain that he described as muscle pain, with shooting pain when raising his left arm in a wing motion.  Patient took 800mg if ibuprofen that relieved the pain.  The arm is still painful to move as of 9/18/2020.
Case number PHEH2016US000982, is a spontaneous report initially received from a health care professional on 07 Jan 2016. This report refers to a 40 year old female patient. Medical history was not reported. Current condition included allergic to Thimerosal. Concomitant medication was not reported. This Thimerosal allergic patient was vaccinated with an initial dose of FLUVIRIN (batch number: 158005) intramuscularly in the right arm on 07 Jan 2016 at 1:51. The reporter confirmed that the patient did not present any adverse event following this administration error. Following an internal review done on 20 Jan 2016, for the data received on 07 Jan 2016 the following correction was done. Coding of the event FLUVIRIN PFS was administered to a patient with a Thimerosal allergy was changed from inadvertent exposure to vaccine to contraindication to vaccination. Follow up information received from the health care professional on 23 Feb 2016: Updated dose number, batch number, route and site of administration of suspect vaccine.
RASH AT INJECTION SITE WARM TO THE TOUCH, RAISED AND RED, NOT ITCHY. LOW FEVER APPROX 99.3,
This spontaneous report was received from a registered nurse and refers to a 14-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 21-DEC-2018, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot # 1586752, expiration date 16-FEB-2021 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (it was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient).; Sender's Comments: US-009507513-1901USA000071:
This case was reported by a consumer via call center representative and described the occurrence of headache in a patient who received SHINGRIX for prophylaxis. The patient's past medical history included Bell's palsy (experienced twice, the last time it was about 10 years before the date of reporting), bypass surgery, headache and weight loss. On 28th January 2019, the patient received SHINGRIX. On 2nd February 2019, 5 days after receiving SHINGRIX, the patient experienced headache. The patient was treated with TYLENOL. On an unknown date, the outcome of the headache was unknown. It was unknown if the reporter considered the headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. On 2nd February 2019, the patient woke up with a headache on the right side in the temple and forehead area. It was a pressure type of headache. The patient inquired if the SHINGRIX shot could have caused this headache. Nothing helped the pain, not even over the counter meds. The patient could not take non-steroidal anti-inflammatory agents due to weight loss or bypass surgery and TYLENOL did not help. The patient was a little concerned and scared.
REC. PFIZER BOOSTER #2 TO LEFT DELTOID. MONITORED X15 MINUTES WITHOUT ANY ILL EFFECTS.  WAS DIAGNOSED WITH UTI YESTERDAY. LATER SENT TO ER SEE NURSES NOTE:  This nurse entered room to give medication and observed resident to be diaphoretic with increases respirations, unable to take medication, lethargic, v/s: T 97.9, 88/58, P107, O2 72% RA, R32, this nurse asked rounding NP to assess resident. NP observed resident and ordered to send to alternate hospital for evaluation and TX, HCP made aware, stat transferred resident at 1740.  RESIDENT WAS ADMITTED TO ER WITH DIAGNOSIS OF HYPOTENSION.
Patient presented with blotches and a rash on face, forearms, and chest. No rash noted on abdomen. Breath sounds equal and clear, no shortness of breath reported. Pulse 76, respirations 14, B/P 133/73 (RA). No itchiness reported. Patient given two Benadryl 25 mg each and observed for 15 minutes.
6x6cm area of erythema, firm induration, tenderness surrounding inject site (appeared 10 hrs p/inject) accompained by fever (tmax 39) lt thigh affected;
12 hours after the first shot, I had severe nausea, abdominal pain. Frequent bowel movements, extreme fatigue, joint pain, muscle pain, bone pain, ear pain, stuffy nose I am slightly better after 12 hours, but plan to spend the day in bed due to severe fatigue and achiness.
Decrease and some loss of taste; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 07May2021 at 08:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D), acetylsalicylic acid (BABY ASPIRIN), and ubidecarenone (CO Q 10) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021 at 12:00, the patient experienced decrease and some loss of taste. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event decrease and some loss of taste was unknown.   No follow-up attempts are needed. No further information is expected.
child presented 10 days after the vaccination with a violacious/vasculitic rash from the deltoid region to the elbow on the vaccinated arm. no systemic symptoms. rash resolved slowly
Post administration patient was discharged to observation by medical assistant to me. I was in the lobby providing break coverage. Patient presented with known COPD and Tremors. Patient had a slight cough when she initially sat down.    After about 5-10 minutes I noted that her respatory rate had increased and coughing had continued. I checked in with the patient and asked how she was feeling initially she reported some nausea no complaints of her breathing. I told the patient that I would be getting the provider just to check things out.    Onsite Provider agreed that patient should be brought to an exam room. Patient walked on her own to Exam room 3. Upon arriving in exam room 3, provider noted hives and arm redness instructed me to deliver Epi. 0.3mg Epi via auro injector was administered at 10:27 to the left thigh area. About 1029 patients breathing did get better. Patient remained alert and conscious. 1032 patient breathing became difficult again, ordered another round of 0.3mg Epi to the right thigh. 1033 breathing was feeling better, ordered patient to use her own Ventolin inhaler to help with some of the breathing problems.    1035 ordered 0.5mg of IM Benadryl, however paramedics arrived on scene and resumed care. Clinic Benadryl was not administered. Patient was transported to ER via Ambulance to hospital for further care.
My arm was just a little sore; Other than a little fatigue after that for a day or so I was fine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient received BNT162b2 (BNT162B2), on 24Mar2021 at 11:00 as dose 1, single (Batch/Lot number: unknown) at the age of 67 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "Other than a little fatigue after that for a day or so I was fine"; PAIN IN EXTREMITY (non-serious) with onset 24Mar2021, outcome "recovered" (Mar2021), described as "My arm was just a little sore". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Covid Vaccine side effects 1st dose 24Mar2021. Patient had the dose at 11 AM and had a stress test at 3:30 that afternoon. Her arm was just a little sore. She sat down to watch a show she recorded and had dinner about 5:30. Took a bite of a mini rice cake and the next thing she knew the phone was ringing waking me up and still had the rice cake in her mouth. Other than a little fatigue after that for a day or so she was fine.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Chills, fever, muscle aches all over the body, headache, watery left eye, upset stomach, night sweats
9-26-2021 2100 Left upper chest pain. Felt like I layed on my arm wrong. Took 1gm tylenol and a warm bath. Pain Resolved. 9-27-2021 0330 Pain returned took 1gm Tylenol and 400mg Ibuprofen pain did not resolve. 0430 Pain began to radiate down left arm went to Hospital.  Triage took EKG that showed Inferior MI. Sat in waiting room pain resolved. After 1 hour left facility to seek help at another facility. Pain returned EKG showed STEMI Troponins + d-dimer+. Sent to Cath Lab at medical center. No occlusions found. Diagnossed with Focal Myocarditis.
Had Shingles 2 years ago (2019). Still feeling some of the affects, but after the Moderna shot, it became worse. Pain of the of Shingles became worse. Noticed hair loss that did not occur before the Modern shot.
This spontaneous report was received from a Medical Assistant referring to a twelve weeks and nine days patient of unknown gender. Pertinent medical history and drug reactions allergies were not reported. On 14-JUN-2016, the patient was inadvertently administered the first dose of ROTATEQ, orally (lot number, expiration date and dose were not reported). Concomitant medications were not reported. There were no adverse effects reported. No product quality complaint (PQC) was involved and no further information was provided. Additional information has been requested.
Pt experienced flushing, chills, nausea, lightheadedness, dizziness directly following vaccination
I had congestion, especially in my nose and very tired. I used one of the home COVID-19 test that came back positive. I called my doctor's office to let them know that I had tested positive for COVID-19 and they had me come into the office. Once I got into the office I discussed my symptoms, I was prescribed the Paxlovid. Within a day of starting the Paxlovid I started feeling better, I was still tired, but I knew I was on the mend.
Mother stated child had red and hard area on outer right thigh approximately the size of a softball on 6/20/00. She noted on 6/21/00, that area was larger, darker red, and harder. Child was taken to physician who gave her a shot of Celestone. The next day the mother stated that the area was purplish in color like a bruise. The child recovered.
Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Date the vial was initially stored in the refrigerator reported as unknown and the vial did not undergo any temperature excursions.  Total number of 168 doses were given from LOT 048C21A.  The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live Follow-Up received contains Non significant information: reporter address
Information has been received from a nurse referring to a 18 year old female patient. The patient has no significant medications to report and no significant medical history. The patient's drug reactions/allergies was reported as none. On an unknown date (reported as "as an infant"), the patient was vaccinated with a series for hepatitis B vaccine (recombinant) 5/05 mcrg/ml (manufacturer unknown) (lot # M006708, expiration date 02-JUN-2018; dose and route were unknown). The reporter stated the patient came to office in July 2016 as her school required hepatitis B protection/vaccination. The reporter stated titers were taken at time of July 2016 visit where titers were discovered to be low. At that time, July 2015, the patient was vaccinated with RECOMBIVAX HB. The reporter stated the patient was doing fine. The outcome of the event was reported as recovered. The causality assessment was not provided. Additional information has been requested.
08/24/2021 around midnight woke up with high fever, headache, chills and body aches. The fever ended after about 24 hours, the headache and body aches lasted for three days.  Still having a lingering pain on the right side below shoulder area.
Moderna COVID-19 Vaccine EUA: Vaccine recipient reported on 1/19/2021 that she developed severe itchiness at the injection site with redness and pain. A lump developed that was warm to touch and increasing induration. On 1/21/2021 she was seen by a family physician and prescribed Bactrim. On 1/23/2021 she went to urgent care and was prescribed clindamycin and amoxicillin. Symptoms lasted 5-6 days after vaccination.